Adenovirus type 5 E1A-induced apoptosis in COX-2-overexpressing breast cancer cells
2007

Celecoxib Enhances E1A-Induced Apoptosis in Breast Cancer Cells

publication 10 minutes Evidence: moderate

Author Information

Author(s): Sugimoto Takeshi, Bartholomeusz Chandra, Tari Ana M, Ueno Naoto T

Primary Institution: The University of Texas M. D. Anderson Cancer Center

Hypothesis

Celecoxib would enhance E1A-induced apoptosis by suppressing Bcl-2 through suppressing COX-2 expression.

Conclusion

Celecoxib enhances E1A-induced apoptosis in breast cancer cells that express high levels of COX-2 protein, partly by blocking the production of PGE2 or PGF2α.

Supporting Evidence

  • Celecoxib increased apoptosis in COX-2-overexpressing breast cancer cells.
  • Blocking PGE2 or PGF2α improved cell viability in celecoxib-treated cells.
  • COX-2 expression was highest in MDA-MB-231-E1A cells, which were more sensitive to celecoxib.

Takeaway

Celecoxib, a drug that reduces inflammation, helps a cancer treatment work better by making cancer cells die more easily.

Methodology

The study involved testing the effects of celecoxib on breast cancer cell lines with varying COX-2 expression levels, assessing cell viability and apoptosis through various assays.

Limitations

The study only examined one COX-2 inhibitor, celecoxib, and the level of E1A expression was not uniform among the cell lines.

Statistical Information

P-Value

0.0002

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1186/bcr1739

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication